WHO Urges Pfizer To Broaden Generic Paxlovid MPP Deal
Move Would ‘Make COVID-19 Drug Available Faster At Affordable Prices’
Executive Summary
As Pfizer’s Paxlovid joins the World Health Organization’s prequalification list, the organization has passed down several recommendations to the US-based Big Pharma, including expanding the scope of countries supplied under an MPP generic licensing agreement.